AST Revolutionizes Fill-Finish: American Pharmaceutical Review’s interview with Josh Russell
Josh Russell, Vice President of Sales and Marketing, recently spoke to American Pharmaceutical Review on AST’s latest aseptic processing solutions. American Pharmaceutical Review, a leading journal for business and technology, connected with Josh at Interphex 2024, where AST exhibited our latest generation GENiSYS® C housed inside AST’s new isolator solution. The exhibit showcased the latest in AST’s barrier and fill-finish innovations and won the prestigious Best in Show award.
Josh discussed what sets AST’s groundbreaking new fill-finish isolator apart, why a modular, turnkey approach to technology is crucial to the time-to-market equation, and how AST will continue to lead with innovation going into the future. The full article is available below:
With the introduction of this new isolator technology, designed in collaboration with Germfree, AST offers the only 100 percent American-made, end-to-end turnkey solutions available in the fill-finish industry.
For a full rundown of the AST solutions showcased at Interphex 2024, check out our in-depth coverage of the conference: Live from New York: Debuting a 100% AST Turnkey Solution.
